Krane Funds Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Krane Funds Advisors’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,961	Closed	-$308K	–	320
2022 Q1	$308K	Buy	18,961 +1,837	+11%	+$47.1K	0.01%	271
2021 Q4	$812K	Sell	17,124 -1,854	-10%	-$111K	0.02%	78
2021 Q3	$1.38M	Sell	18,978 -656	-3%	-$47.4K	0.03%	62
2021 Q2	$1.65M	Buy	19,634 +19,433	+9,668%	+$1.28M	0.05%	57
2021 Q1	$10K	Hold	201	–	–	﹤0.01%	289
2020 Q4	$9K	Buy	+201	New	+$7.92K	﹤0.01%	293

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Krane Funds Advisors's NBP Position: Q2 2022 in Review

Krane Funds Advisors sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 18,961 shares — an estimated $308K sold.

Krane Funds Advisors first reported a position in NBP in Q4 2020 and held it in 6 quarters. The position peaked at $1.65M in Q2 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

Krane Funds Advisors reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Krane Funds Advisors sold 18,961 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $308K.
Krane Funds Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 6 quarters.
Krane Funds Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $1.65M in Q2 2021.
97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Krane Funds Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.